Stay updated on Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe footer now identifies the site revision as v3.8.1 instead of v3.8.0.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe ClinicalTrials.gov page footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check29 days agoChange DetectedA site-wide NIH notice says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference0.6%

- Check36 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2, while the study record history remains unchanged.SummaryDifference0.1%

- Check43 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision entry v3.7.0 was added to the study record history, and the entry for v3.6.6 was removed from the history.SummaryDifference0.1%

Stay in the know with updates to Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial page.